BIOLOTEGACC — MERGEN RESEARCH SRL (Q2023771)

From EU Knowledge Graph
Revision as of 06:02, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2023771 in Italy
Language Label Description Also known as
English
BIOLOTEGACC — MERGEN RESEARCH SRL
Project Q2023771 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    467,854.95 Euro
    0 references
    budget
    623,806.6 Euro
    0 references
    co-financing rate
    75.0 percent
    0 references
    start time
    22 October 2017
    0 references
    expected end time
    16 October 2019
    0 references
    beneficiary name (string)
    ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE SENATORE G. PASCALE
    0 references
    MERIGEN RESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
    0 references
    beneficiary
    Q278445
    0 references
    Q278494
    0 references
    programme
    Campania - ERDF
    0 references
    coordinate location

    40°50'9.35"N, 14°14'55.61"E
    0 references
    summary
    BIOMOLTEACC - MERIGEN RESEARCH SRL - PROGETTI TRASFERIMENTO TECNOLOGICO E DI PRIMA INDUSTRIALIZZAZIONE PER LE IMPRESE INNOVATIVE AD ALTO POTENZIALE PER LA LOTTA ALLE PATOLOGIE ONCOLOGICHE (Italian)
    0 references
    BIOLEDACC — MERGEN RESEARCH SRL — TECHNOLOGY TRANSFER AND FIRST INDUSTRIALISATION PROJECTS FOR INNOVATIVE HIGH-POTENTIAL COMPANIES TO FIGHT CANCER DISEASES (English)
    0 references

    Identifiers

    Italian Unique Project Code
    B63D18000220007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2023771&oldid=7625135"